These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 21327911
1. Contribution of pH to systemic exposure of niflumic acid following oral administration of talniflumate. Kim E, Kang W. Eur J Clin Pharmacol; 2011 Apr; 67(4):425-428. PubMed ID: 21327911 [Abstract] [Full Text] [Related]
2. Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate. Kang W, Kim K, Kim EY, Kwon KI, Bang JS, Yoon YR. Eur J Clin Pharmacol; 2008 Oct; 64(10):1027-30. PubMed ID: 18607579 [Abstract] [Full Text] [Related]
3. Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography. Jang DJ, Park JS, Ko HR, Jee JP, Kim JK, Kim ST, Kim CK. Biomed Chromatogr; 2005 Jan; 19(1):32-5. PubMed ID: 15470687 [Abstract] [Full Text] [Related]
4. Liquid chromatography-mass spectrometric method for the sensitive determination of niflumic acid in human plasma and its application to pharmacokinetic study of talniflumate tablet. Park EJ, Na DH, Shin YH, Lee KC. J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec 15; 876(2):159-62. PubMed ID: 19010744 [Abstract] [Full Text] [Related]
5. Pharmacokinetic comparison of two formulations of talniflumate 370 mg tablets in healthy Korean volunteers . Kim Y, Yim S, Kim BH, Lee S. Int J Clin Pharmacol Ther; 2017 Jan 15; 55(1):102-108. PubMed ID: 27879193 [Abstract] [Full Text] [Related]
6. Determination of talniflumate and niflumic acid in human plasma by liquid chromatography-tandem mass spectrometry. Kang W, Kim K. Anal Sci; 2009 Apr 15; 25(4):571-4. PubMed ID: 19359802 [Abstract] [Full Text] [Related]
7. Quantitation of niflumic acid in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection and its application to a bioequivalence study of talniflumate tablets. Lee HW, Won KJ, Cho SH, Ha YH, Park WS, Yim HT, Baek M, Rew JH, Yoon SH, Yim SV, Chung JH, Lee KT. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul 25; 821(2):215-20. PubMed ID: 15921965 [Abstract] [Full Text] [Related]
8. The effect of antacid and ranitidine on droxicam pharmacokinetics. Bartlett A, Costa A, Martínez L, Roser R, Sagarra R, Sánchez J. J Clin Pharmacol; 1992 Dec 25; 32(12):1115-9. PubMed ID: 1487550 [Abstract] [Full Text] [Related]
9. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin. Mück W, Ritter W, Dietrich H, Frey R, Kuhlmann J. Int J Clin Pharmacol Ther; 1997 Jun 25; 35(6):261-4. PubMed ID: 9208343 [Abstract] [Full Text] [Related]
10. Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. Neuvonen PJ, Kivistö KT. Eur J Clin Pharmacol; 1988 Jun 25; 35(5):495-501. PubMed ID: 3266151 [Abstract] [Full Text] [Related]
11. The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics. Martin PD, Schneck DW, Dane AL, Warwick MJ. Curr Med Res Opin; 2008 Apr 25; 24(4):1231-5. PubMed ID: 18355422 [Abstract] [Full Text] [Related]
12. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers. Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z. Pharmacotherapy; 2007 Jul 25; 27(7):963-9. PubMed ID: 17594201 [Abstract] [Full Text] [Related]
13. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir. Krishna R, East L, Larson P, Valiathan C, Butterfield K, Teng Y, Hernandez-Illas M. J Pharm Pharmacol; 2016 Nov 25; 68(11):1359-1365. PubMed ID: 27671833 [Abstract] [Full Text] [Related]
14. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers. Grunder G, Zysset-Aschmann Y, Vollenweider F, Maier T, Krähenbühl S, Drewe J. Antimicrob Agents Chemother; 2006 Jan 25; 50(1):68-72. PubMed ID: 16377669 [Abstract] [Full Text] [Related]
15. Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol. Carsenti-Etesse H, Farinotti R, Durant J, Roger PM, De Salvador F, Bernard E, Rouveix B, Dellamonica P. Eur J Drug Metab Pharmacokinet; 1998 Jan 25; 23(3):357-66. PubMed ID: 9842977 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers. Coates PE, Mesure R. Br J Clin Pharmacol; 1995 Jan 25; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087 [Abstract] [Full Text] [Related]
17. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers. Stass H, Böttcher MF, Ochmann K. Clin Pharmacokinet; 2001 Jan 25; 40 Suppl 1():39-48. PubMed ID: 11352441 [Abstract] [Full Text] [Related]
18. Effect of an orally administered antacid agent containing aluminum hydroxide and magnesium hydroxide on abomasal luminal pH in clinically normal milk-fed calves. Ahmed AE, Constable PD, Misk NA. J Am Vet Med Assoc; 2002 Jan 01; 220(1):74-9. PubMed ID: 12680452 [Abstract] [Full Text] [Related]
19. Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids. Snell P, Oo C, Dorr A, Barrett J. Br J Clin Pharmacol; 2002 Oct 01; 54(4):372-7. PubMed ID: 12392584 [Abstract] [Full Text] [Related]
20. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses. Clark CK, Merritt AM, Burrow JA, Steible CK. J Am Vet Med Assoc; 1996 May 15; 208(10):1687-91. PubMed ID: 8641951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]